Of note, previous studies have suggested that HSP90 can influence the activation and stability of crucial regulators involved in the necroptosis process, such asRIPK1, RIPK3 and MLKL, thereby contributing to immune cell recruitment and immunogenic cell death of tumor cells (77–79). Here, HSP90AA1 is linked to neoplasm.